Bayer Cropscience Q2 Results FY27 Preview: Results Date, Expectations and the Numbers That Will Decide the September 2026 Quarter
- September 17, 2026
- Posted by: Harsh Piplani
- Category: Results
Bayer Cropscience share price Rs 3,899.60 on 17 September 2026, down 0.99%. Q2 FY27 results date not confirmed. Q1 FY27 net profit Rs 322.00 crore. Q2 FY26 base a profit of Rs 153.00 crore.
Quick Answer
The Bayer Cropscience Q2 results date for FY27 is not confirmed, and Bayer CropScience Ltd. had not filed a board meeting intimation with the NSE or BSE as of 17 September 2026. Indian listing rules require the September 2026 quarter results to be published within 45 days of the quarter end, an outer deadline of 14 November 2026. The quarter will be measured against a September 2025 base of Rs 1,553.00 crore in revenue and a profit of Rs 153.00 crore. This preview uses reported actuals only and carries no estimated revenue or profit figure for the coming quarter.
The Bayer Cropscience Q2 results FY27 announcement is the next scheduled earnings event for Bayer CropScience Ltd., Bayer Cropscience develops, manufactures and sells crop protection chemicals, seeds and agricultural solutions to farmers and distributors in India.. The stock traded at Rs 3,899.60 on the NSE on 17 September 2026, down 0.99% from the previous close of Rs 3,938.60, about 29.0% below its 52-week high of Rs 5,489.00 and 0.4% above its 52-week low of Rs 3,885.30.
What makes the Bayer Cropscience Q2 results print worth watching is the base it faces. The September 2025 quarter delivered Rs 1,553.00 crore of revenue and a profit of Rs 153.00 crore, while the most recent quarter on record, Q1 FY27, produced Rs 1,835.00 crore and a profit of Rs 322.00 crore. Everything below is built from those reported figures rather than from any forecast.
Click Here – Get Free Investment Predictions
When Is the Bayer Cropscience Q2 Results FY27 Date?
The Bayer Cropscience Q2 results date for FY27 is not confirmed. As of 17 September 2026, Bayer CropScience Ltd. had not filed a board meeting intimation with the NSE or BSE for the September 2026 quarter, so any date circulating before that filing appears should be treated as unverified.
Also read – India Glycols Q2 Results FY27 Preview: Results Date, Expectations
What can be stated is the regulatory boundary. Listed companies in India must publish quarterly results within 45 days of the end of the quarter, which places the outer deadline for the September 2026 quarter at 14 November 2026. Companies also have to give the exchanges prior intimation of the board meeting that approves the results, so the Bayer Cropscience Q2 results date becomes public through that filing rather than through any advance announcement.
The Bayer Cropscience Q2 results FY27 print covers 1 July 2026 to 30 September 2026. Small and mid-cap companies more often report in the second half of that window than in the first, so late October or early November is the range to watch for Bayer Cropscience.
Bayer Cropscience Q2 Results Expectations: What the Market Is Actually Tracking
No verified analyst estimate for the Bayer Cropscience Q2 results FY27 quarter is in the public domain, so no revenue or profit figure should be assumed for Bayer Cropscience. The Bayer Cropscience Q2 results watchlist below is built from what the company has actually reported and disclosed.
Bayer Cropscience Q2 results for the September 2026 quarter follow a clear seasonal decline-and-recovery pattern seen over the last five quarters. Revenue fell from Rs 1,915 crore in the June 2025 quarter to Rs 1,553 crore, then to Rs 1,106 crore and Rs 1,101 crore over the following two quarters, before rebounding sharply to Rs 1,835 crore in the June 2026 quarter. Net profit tracked the same shape, dropping from Rs 279 crore to Rs 96 crore across three quarters before climbing back to Rs 322 crore in June 2026, and this swing looks tied to the seasonal nature of the agrochemical business rather than a structural change, a pattern that will shape how Bayer Cropscience Q2 results for the September 2026 quarter are interpreted against the year-ago base.
Operating margin for Bayer Cropscience has moved in the same seasonal rhythm, sliding from 18% to as low as 11% in the December 2025 quarter before recovering to 20% by June 2026, the strongest margin of the five quarters shown. A return on equity of 23.7% and return on capital employed of 29.1% are strong figures that point to a business with real pricing power in crop protection and seeds, even though quarterly results swing with the agricultural sowing calendar. Monsoon performance, kharif and rabi sowing patterns, and input cost trends for crop protection chemicals are the sector-level factors most likely to influence Bayer Cropscience Q2 results this time around.
Also read – Gujarat Fluorochemicals Q2 FY27 Preview: Revenue, Margin & Profit Trend
Putting it together, the run-up to the September 2026 quarter shows a business whose quarterly numbers move with the agricultural season rather than in a straight line, with the weakest quarters typically falling in the December to March window and the strongest around the June sowing period. Bayer Cropscience Q2 results for the September 2026 quarter will need to be read against this seasonal backdrop rather than compared directly to the immediately preceding quarter. At a price to earnings ratio of 24.2 and a dividend yield of 3.81%, the market appears to already price in this cyclicality, treating full-year profitability as the more relevant measure than any single quarter in isolation. That seasonal lens is essential context for Bayer Cropscience Q2 results this quarter.
Check Bayer CropScience Ltd. Live Fundamentals on the Univest Screener
Bayer Cropscience Q2 Results Preview: The Q1 FY27 Actuals It Builds On
Bayer CropScience Ltd. reported revenue of Rs 1,835.00 crore in Q1 FY27, down 4.18% from Rs 1,915.00 crore in Q1 FY26, and a profit of Rs 322.00 crore at the net level, up 15.41% from Rs 279.00 crore in Q1 FY26. These are reported actuals, not estimates.
Sequentially, revenue was up 66.67% over the March 2026 quarter figure of Rs 1,101.00 crore, and net profit was up 98.77% from Rs 162.00 crore in Q4 FY26. Operating margin stood at 18.0% in Q1 FY27 against 13.0% in the September 2025 quarter, which is the comparison the Bayer Cropscience Q2 results print will be read against.
Q2 FY26 Base: The Comparison Bayer Cropscience Q2 Results FY27 Must Beat
Bayer CropScience Ltd. reported revenue of Rs 1,553.00 crore and a profit of Rs 153.00 crore in Q2 FY26, the September 2025 quarter. That is the year-ago base against which the September 2026 numbers will be judged, and it is the single most useful figure in this Bayer Cropscience Q2 results preview.
Net profit in that base quarter was below the Rs 322.00 crore just reported for Q1 FY27, so the year-on-year comparison starts from a manageable level. Revenue of Rs 1,553.00 crore sits below the Rs 1,835.00 crore of the June 2026 quarter, which frames how much sequential movement the Bayer Cropscience Q2 results print needs to show growth.
Bayer Cropscience Quarterly Results Trend Over the Last Four Quarters
| Quarter | Revenue (Rs Cr) | Net Profit (Rs Cr) |
|---|---|---|
| Q2 FY26 (Sep 2025) | 1,553.00 | 153.00 |
| Q3 FY26 (Dec 2025) | 1,106.00 | 96.00 |
| Q4 FY26 (Mar 2026) | 1,101.00 | 162.00 |
| Q1 FY27 (Jun 2026) | 1,835.00 | 322.00 |
Figures in brackets denote negative numbers. All four quarters above are reported actuals taken from the company’s exchange filings, and they are the only basis this Bayer Cropscience Q2 results preview uses.
Revenue across those four quarters ranged from Rs 1,101.00 crore to Rs 1,835.00 crore, and net profit from Rs 96.00 crore to Rs 322.00 crore. That spread is the honest context for the Bayer Cropscience Q2 results FY27 print, and it is why a single quarter should not be read as a trend on its own.
Key Factors That Could Shape Bayer Cropscience Q2 Results FY27
The Bayer Cropscience Q2 results outcome will turn on a small number of company-specific variables rather than on broad market conditions. The three below are the ones visible in what Bayer Cropscience has already reported.
Seasonal Swing in Revenue and Profit
The dominant pattern behind Bayer Cropscience Q2 results is seasonality: revenue and net profit both fell for three straight quarters before jumping sharply in June 2026, a shape that lines up with the agricultural sowing calendar rather than signaling deterioration or improvement in the core business. Anyone comparing the September 2026 quarter to the immediately preceding quarter should keep this seasonal pattern in mind rather than reading a sequential change as a trend on its own.
Monsoon and Sowing-Linked Demand
Crop protection and agrochemical sales are directly tied to sowing activity, so monsoon adequacy and kharif sowing trends heading into the second half of the year are likely to be as important to Bayer Cropscience Q2 results as anything company-specific. A repeat of the 20% operating margin seen in June 2026 would suggest healthy underlying demand, while a reversion toward the 11% to 13% margins seen in the December and September 2025 quarters would point to weaker input demand or pricing pressure.
Strong Returns Support the Valuation
Return on equity of 23.7% and return on capital employed of 29.1% are well above what most industrial or consumer businesses generate, and they give Bayer Cropscience Q2 results a favorable backdrop even accounting for the quarter-to-quarter volatility in reported numbers. With low debt on the balance sheet and a dividend yield of 3.81%, the company has historically converted its seasonal profit swings into consistent full-year returns for shareholders, which is the more relevant benchmark than any single quarter’s results.
Bayer Cropscience Q2 Results FY27: Share Price and Valuation Going Into the Print
Bayer Cropscience share price today is Rs 3,899.60 on the NSE, down Rs 39.00 or 0.99% from the previous close of Rs 3,938.60 on 17 September 2026, ahead of the Bayer Cropscience Q2 results announcement.
| Metric | Value (17 September 2026) |
|---|---|
| NSE Symbol | BAYERCROP |
| Current Market Price | Rs 3,899.60 |
| 52-Week High | Rs 5,489.00 |
| 52-Week Low | Rs 3,885.30 |
| Market Capitalisation | Rs 17525 crore |
| PE Ratio | 23.96 |
| PB Ratio | 5.91 |
| EPS (TTM) | Rs 162.77 |
| Book Value per Share | Rs 660.00 |
| Debt to Equity | 0.03 |
| Return on Equity | 23.7% |
| 50-Day Moving Average | Rs 3938.14 |
| 200-Day Moving Average | Rs 3952.06 |
| RSI (14) | 49.03 |
The stock trades below both its 50-day average of Rs 3938.14 and its 200-day average of Rs 3952.06, with a 14-day RSI of 49.03. None of this is a view on where the shares go once the Bayer Cropscience Q2 results are announced, and no price target is offered here.
Download the Univest iOS App or Univest Android App to track Bayer CropScience Ltd. live price and quarterly earnings updates.
What Investors Should Watch When Bayer Cropscience Q2 Results Are Announced
Four lines carry most of the information in a company of this size, and reading them in order keeps the Bayer Cropscience Q2 results print in proportion.
- Revenue against the Rs 1,553.00 crore reported in the September 2025 base quarter
- Net profit against a profit of Rs 153.00 crore in that same quarter
- Operating margin against 18.0% in Q1 FY27
- Any exceptional item, provision or one-off gain disclosed alongside the numbers
A one-off gain or provision can move the reported profit far more than operations do in a company this size, which is why the Bayer Cropscience Q2 results announcement should be read together with the notes to the results rather than the headline alone.
Conclusion on Bayer Cropscience Q2 Results FY27
The Bayer Cropscience Q2 results date is not confirmed, and 14 November 2026 is the statutory outer limit rather than an expected date. Bayer CropScience Ltd. will make the schedule public through a board meeting intimation to the exchanges, and until then the September 2026 quarter can only be framed by what has already been reported.
On that basis the Bayer Cropscience Q2 results FY27 print faces a base of Rs 1,553.00 crore in revenue and a profit of Rs 153.00 crore, with the most recent quarter having delivered Rs 1,835.00 crore and a profit of Rs 322.00 crore. No numerical estimate appears in this preview because no verified consensus figure exists for Bayer Cropscience, and readers should treat any preview that supplies one with caution. Verify every figure against the company filing on release and consult a SEBI-registered advisor before acting on quarterly earnings.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
FAQs on Bayer Cropscience Q2 Results FY27
What is the Bayer Cropscience Q2 results date for FY27?
Ans. The Bayer Cropscience Q2 results date for FY27 is not confirmed. Bayer CropScience Ltd. had not filed a board meeting intimation with the NSE or BSE as of 17 September 2026. Indian listing rules require the September 2026 quarter results to be published by 14 November 2026 at the latest.
What quarter do the Bayer Cropscience Q2 results 2026 cover?
Ans. The Bayer Cropscience Q2 results FY27 cover 1 July 2026 to 30 September 2026, known as the September 2026 quarter. Bayer CropScience Ltd. reports revenue, operating profit and net profit for that period, and the Bayer Cropscience Q2 results filing also carries the notes to the accounts.
What were the Bayer Cropscience Q1 FY27 results?
Ans. Bayer CropScience Ltd. reported revenue of Rs 1,835.00 crore in Q1 FY27 and a profit of Rs 322.00 crore at the net level. Revenue was down 4.18% versus Q1 FY26 and net profit was up 15.41% from Rs 279.00 crore in Q1 FY26.
What were Bayer Cropscience Q2 FY26 results in the September 2025 quarter?
Ans. Bayer CropScience Ltd. reported revenue of Rs 1,553.00 crore and a profit of Rs 153.00 crore in Q2 FY26. Operating margin was 13.0%. Those figures form the base for the Bayer Cropscience Q2 results FY27 comparison.
What are the main Bayer Cropscience Q2 results expectations this quarter?
Ans. No verified analyst estimate is publicly available. The Bayer Cropscience Q2 results expectations centre on revenue against the Rs 1,553.00 crore base, net profit against a profit of Rs 153.00 crore, operating margin against 18.0% in Q1 FY27, and any exceptional item disclosed with the numbers.
What is Bayer Cropscience share price today ahead of the Q2 earnings?
Ans. Bayer Cropscience share price is Rs 3,899.60 on the NSE as of 17 September 2026, down 0.99% from Rs 3,938.60. The stock is about 29.0% below its 52-week high of Rs 5,489.00 and 0.4% above its 52-week low of Rs 3,885.30, at a market capitalisation of Rs 17525 crore.
Is Bayer Cropscience a good stock to buy before the Q2 results?
Ans. This article does not offer a buy, sell or hold recommendation on Bayer CropScience Ltd. The stock trades at a price-to-book ratio of 5.91 with a return on equity of 23.7%. Assess the reported numbers when they are released and consult a SEBI-registered financial advisor before making any decision.
